Can an innocuous aquatic plant manufacture disease-curing proteins? Drug companies already use genetically engineered bacteria to produce therapeutic proteins such as Factor IX, a blood component that hemophiliacs lack. Others are trying to insert genes into the cells of animals so that the animals can produce specific proteins in their milk.
Anne-Marie Stomp, a professor of forestry at North Carolina State University, says humble duckweed could best both bugs and beasts. The tiny plant may top animals because it is “clonal”-it buds off copies of itself-which means genetic changes will stay intact in succeeding generations. The fast-growing plant can produce more sophisticated proteins than bacteria, says Stomp, and can thrive in an industrial setting. Stomp has started a company, Biolex, to teach the plants to secrete proteins for easy collection.
DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.
“This is a profound moment in the history of technology,” says Mustafa Suleyman.
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
Human-plus-AI solutions mitigate security threats
With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure
Next slide, please: A brief history of the corporate presentation
From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.